TABLE 1.
Measure | All Subjects | AT Subjects | NA Subjects | P |
---|---|---|---|---|
Age, y | 71.5 ± 0.7 | 71.8 ± 1.1 | 71.2 ± 0.9 | 0.420 |
Body mass, kg | 81.0 ± 2.1 | 83.5 ± 2.6 | 79.3 ± 3.1 | 0.343 |
Height, m | 1.68 ± 0.01 | 1.66 ± 0.03 | 1.69 ± 0.02 | 0.532 |
Body mass index, kg/m2 | 28.6 ± 0.63 | 30.1 ± 1.0 | 27.7 ± 1.0 | 0.061 |
Waist to hip ratio | 0.95 ± 0.01 | 0.97 ± 0.02 | 0.94 ± 0.02 | 0.291 |
Blood pressure, mm Hg | ||||
Systolic | 143 ± 3 | 149 ± 6 | 139 ± 4 | 0.123 |
Diastolic | 85 ± 2 | 83 ± 2 | 86 ± 2 | 0.329 |
Mean | 104 ± 2 | 105 ± 3 | 104 ± 3 | 0.723 |
Heart rate, beats/min | 64.5 ± 1.7 | 66.1 ± 2.8 | 62.8 ± 1.9 | 0.340 |
Fasting blood glucose, mEq1 | 7.5 ± 0.3 | 7.9 ± 0.6 | 7.1 ± 0.3 | 0.22 |
Glycosylated hemoglobin, % | 6.5 ± 0.1 | 6.7 ± 0.2 | 6.4 ± 0.1 | 0.432 |
Lipid profile, mmol/L | ||||
Total cholesterol | 4.7 ± 0.2 | 5.0 ± 0.2 | 4.6 ± 0.3 | 0.290 |
LDL cholesterol | 2.6 ± 0.2 | 2.6 ± 0.8 | 2.5 ± 0.2 | 0.592 |
HDL cholesterol | 1.5 ± 0.1 | 1.5 ± 0.1 | 1.5 ± 0.1 | 0.619 |
BRS, ms/mm Hg | ||||
All sequences | 9.12 ± 0.93 | 8.85 ± 1.67 | 9.31 ± 1.08 | 0.975 |
Upward sequences | 8.65 ± 1.11 | 8.06 ± 2.03 | 9.08 ± 1.25 | 0.957 |
Downward sequences | 9.46 ± 0.82 | 9.27 ± 1.37 | 9.60 ± 1.03 | 0.824 |
Baseline data for aerobically trained (AT), untrained (NA) and all subjects are shown as mean ± standard error. A P value of < 0.05 was considered significant.
HDL, high-density lipoprotein; LDL, low-density lipoprotein.